| Market Cap | ₹19,960Cr |
| ROE | 2.34% |
| P/E Ratio(TTM) | 499.13 |
| EPS(TTM) | 3.49 |
| P/B Ratio | 3.38 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.14 |
| Book Value | 515.29 |
| Debt to Equity | 0.22 |
| Face Value | 1 |
| Parent Organisation | Onesource Specialty Pharma |
| NSE Symbol | ONESOURCE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 69.34 | ||
| Anthem Biosciences | NA (0.00%) | 71.16 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 21.97 | ||
| Panacea Biotec | NA (0.00%) | -328.27 |